Clinical Trial Update: A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating etelcalcetide in pediatric patients with secondary hyperparathyroidism due to chronic kidney disease on hemodialysis; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Etelcalcetide (etelcalcetide)

Snippet

Sponsor: Amgen | Conditions: Secondary Hyperparathyroidism, Chronic Kidney Disease | Phase 3 | Status: RECRUITING